Skip to main content
Clinical Trials/NCT03060668
NCT03060668
Completed
Not Applicable

Optimized Caloric-proteic Nutrition in Critically Ill Patients: Impact on Short and Long-term Outcomes

Hospital Sao Domingos1 site in 1 country138 target enrollmentJune 2016
ConditionsCritically Ill

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Critically Ill
Sponsor
Hospital Sao Domingos
Enrollment
138
Locations
1
Primary Endpoint
PCS of SF-36
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

In this prospective randomized controlled trial the investigators intend to compare the use of a nutritional therapy based on caloric intake determined by indirect calorimetry and a high protein intake (2.0 to 2.2 g/kg/day) with a nutritional regimen based on 25 Kcal/kg/day and protein intake usually recommended to critically ill patients (1.4 to 1.5 grams/kg/day).

Detailed Description

OBJECTIVES To evaluate the effect of nutritional therapy with caloric intake determined by indirect calorimetry and high protein intake (2.0 to 2.2 g/kg/day) compared to nutritional therapy with 25 kcal/kg/day and 1.4 to 1, 5 g/kg/day of protein on short-term outcomes and physical component (PCS) of quality of life after 3 and 6 months of randomization in severe ICU patients. The primary objective will be the evaluation of the physical component summary (PCS) of SF-36 (Short Form 36), a questionnaire used to evaluate quality of life, validated for the Brazilian population. Patients will be assessed at least 3 and 6 months after randomization. Secondary objectives: Measurement of handgrip strength measured on the 7th and 14th day of the study and on discharge from the ICU, ICU mortality, hospital mortality, mechanical ventilation time and length of stay in the ICU. METHODS The study will include patients over 18 years of age, not pregnant, submitted to mechanical ventilation, whose expectation of stay in the ICU is greater than 3 days. The sample size was calculated based on the following parameters: patient population under mechanical ventilation, 528, 15% relative risk reduction in the evaluation parameter of the SF-36 tool, Level of significance (α) of 5%, test power of 80%, thus the number of individuals to be sampled will be 294, i.e., two groups of 147 patients. A computer-generated list for randomization and sequentially numbered opaque sealed envelopes is used. The level of significance to reject the null hypothesis will be 5%, that is, a value of p \<0.05 will be considered as statistically significant. Informed consent was obtained from the patient or a next of kin.

Registry
clinicaltrials.gov
Start Date
June 2016
End Date
December 2018
Last Updated
4 years ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

José Raimundo Araujo de Azevedo

PhD

Hospital Sao Domingos

Eligibility Criteria

Inclusion Criteria

  • Critically ill patients Mechanically ventilated Expected length in the ICU \> 3 days

Exclusion Criteria

  • Pregnancy Requirement for inspired oxygen (FIO2) \> 0.60 High output bronchopleural fistula

Outcomes

Primary Outcomes

PCS of SF-36

Time Frame: 6 months after randomization

Physical component summary of Short Form 36

Secondary Outcomes

  • Handgrip strength(7th, 14th after admission and up to 30 days)
  • ICU mortality(Up to 30 days)
  • Hospital mortality(Up to 6 months)

Study Sites (1)

Loading locations...

Similar Trials